Merger and acquisition activity remains “a key component” of Uniphar’s strategy, said chairman Maurice Pratt. Photograph: Dara Mac Donaill
In a statement issued in advance of its annual general meeting on Thursday, chairman Maurice Pratt said performance in the first four months had been in line with the group’s expectations. “The group achieved a significant milestone of doubling 2018 pro forma EBITDA ahead of the time frame committed to at the time of IPO (initial public offering,” Mr Pratt said. “We also announced a new ambitious target of growing group EBITDA to €200 million over the medium-term. This will be achieved through a combination of strong organic growth complemented with acquisitions that meet our disciplined strategic and financial criteria.
“I am pleased to report a good start to 2024, with performance in the first four months in line with the board’s expectations” Mr Pratt said. “Uniphar remains well positioned to deliver organic gross profit growth across each division in line with previous guidance and to deliver expectations for the full year.”
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Uniphar's performance in line with expectationsHealthcare services group Uniphar has reported a good start to 2024, with performance in the first four months in line with the Board's expectations.
Source: RTEbusiness - 🏆 16. / 61 Read more »